麻豆传媒

Diana Swift

Diana Swift

Authors >

Diana Swift

Diana Swift is a freelance medical journalist based in Toronto. She has been a medical writer, editor and consumer health editor since 1988.

Connect:

email image

Latest from Diana Swift

Illustration of pills, syringe, IV bag with text 1st in a circle over a uterus with endometriosis

For Your Patients: What to Know About Endometriosis Treatment

Medical, surgical, and lifestyle approaches can help

Illustration of a stethoscope with an electrocardiogram over a uterus with endometriosis

Diagnosing Endometriosis

Surgery plus pathology is gold standard, but symptoms and clinical exam can kick-start treatment

Illustration of a stethoscope with an electrocardiogram over a uterus with endometriosis

For Your Patients: How Will Your Doctor Diagnose Endometriosis?

Symptoms, physical exam, and imaging tests all play a role

Illustration of the letter i over a hand over a uterus with endometriosis

Endometriosis: Understanding the Pathogenesis and Pathophysiology

Complex genetic, physiologic, and environmental interactions drive this multifactorial disease

Illustration of the letter i over a hand over a uterus with endometriosis

For Your Patients: What Is Endometriosis?

Could you be suffering from this painful disease?

Chamara Basnayake on Multidisciplinary Care for Functional GI Disorders

Patients reported superior outcomes at 1 year compared with gastroenterologist-only standard care

ASH over a photo of the Georgia World Conference Center in Atlanta, GA.

Clinical Challenges: Using MRD in Chronic Lymphocytic Leukemia Management

Early indications that it could be used to guide the length of fixed-duration therapy

ASH over a photo of the Georgia World Conference Center in Atlanta, GA.

Clinical Challenges: Complications of CLL

Side effects of novel treatments differ from those of traditional chemotherapy

A female doctor checks in with a mature woman receiving chemotherapy treatment at an infusion center.

Clinical Challenges: Optimizing Infection Prophylaxis in AML

Approach should be three-pronged and tailored to the patient, experts say

A close up of an IV drip next to a vial of Keytruda (pembrolizumab) with an out of focus senior man in the background

First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancer

Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes

鈥�

9

鈥�